Terapia's

Ranbaxy could sell Terapia's facilities in Bucharest

Indian-based Ranbaxy intends to sell Terapia's oral liquid business in Bucharest, according to the Indian Economic Times. Ranbaxy has already been in talks with a number of global companies and the estimated value of this division stands at 15-20 million dolla...